KIVIPharm is a leading & fastest growing Chinese pharma. Our focus has long been on Small Volume Parenterals (SVP) dosage form. Since inception in 1973, KIVIPharm has always been showing strong commitment towards manufacturing & supplying quality generic medicines at affordable prices. Our newly set up state-of-the-art Injectable facility has achieved GMP compliance certificate from China FDA as well as other authorities. In addition to China domestic market, KIVIPharm has been supplying generic medicines to more than 50 countries, mainly in Middle-East Asia, South-East Asia, Russia & CIS, South America and Africa. "Quality Medicine for Healthy Living" is our slogan- we have firm belief on it. As a part of our commitment towards continuous improvement, we are expanding our product portfolio & manufacturing operations into Oral Solid dosage forms, mainly for regulated markets. The project is at its advanced stage of implementation. This facility is designed to be fully compliant to the GMP requirements of stringent regulatory authorities of WHO, Northern America, EU, Australia, etc. With further expansion plan we have project to set up new injectable facility for regulated markets by 2018. Through our offering of high-quality, lower-cost generic medicines, we continue to help reduce the treatment cost —improved affordability of care for patients. For more details, please contact: info@kivipharm.com or sales@kivipharm.com